Two stocks from that list that strike me as particularly strong buys this month are Merck (NYSE: MRK) and Kraft Heinz (NASDAQ: KHC). But what investors are likely most bullish about right now is the company's COVID-19 pill, molnupiravir, which has demonstrated in a phase 3 study that it can cut the risk of hospitalization or death for people with mild or moderate COVID-19 by 50%. For instance, Kraft is coming off a solid earnings beat in its most recent quarter -- benefiting from price increases that helped offset inflation.